BioCentury
ARTICLE | Clinical News

Myobloc: Phase III started

November 25, 2013 8:00 AM UTC

US WorldMeds began a double-blind, placebo-controlled, U.S. Phase III trial to evaluate Myobloc injected into the salivary glands every 13 weeks for up to a year in about 180 patients. The product is ...